The latest cancer drugs news
Browsing: Cancer Drug News
Prostate cancer drug combination shows promise in early trial
A combination of two drugs for prostate cancer is safe and shows signs of effectiveness…
Study provides path for new immunotherapy approaches to prostate cancer
Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways…
Breast cancer drugs stop working when tumours ‘make their own fuel’
Scientists have discovered why a type of breast cancer drug stops working in some patients.…
‘First in human’ trial defines safe dosage for ONC201 for solid tumours
A ‘first in human’ clinical trial examining the small molecule drug ONC201 in cancer patients…
Oncology nurse protection: time for more precise legislation on exposure to hazardous drugs?
Independent research organisation MindMetre, which regularly addresses patient and healthcare worker safety across Europe, has…
New research set to improve traditional Chinese cancer treatment
Dried skin secretions from toads could soon be used in a treatment for the benefit…
Updated phase II results of sulfatinib for neuroendocrine tumours
Data from the ongoing phase Ib/II clinical trial of sulfatinib in patients with advanced neuroendocrine…
New trial updates for rucaparib for advanced ovarian cancer
New data from parts 1 and 2 of the ongoing ARIEL2 phase II trial was presented…
Three drug combination extends survival for patients with multiple myeloma
For newly diagnosed patients with multiple myeloma who plan to delay autologous stem cell transplantation,…
Mechanism triggering spread of prostate cancer to bones found
A Washington State University researcher has found a way that prostate cancer cells hijack the…